Document:

EXHIBIT 4.1

 

EXHIBIT A

 

Form of Representative’s Warrant Agreement

 

THE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY
ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED
HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD
OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE EFFECTIVE DATE (DEFINED BELOW) TO ANYONE OTHER THAN (I) EF HUTTON, DIVISION OF BENCHMARK INVESTMENTS,
LLC OR AN UNDERWRITER OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE OFFICER OR PARTNER OF EF HUTTON, DIVISION
OF BENCHMARK INVESTMENTS, LLC OR OF ANY SUCH UNDERWRITER OR SELECTED DEALER.

 

THIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR
TO _____________, 2022.

VOID AFTER 5:00 P.M., EASTERN TIME, ___________,
2027.

 

ORDINARY SHARES PURCHASE WARRANT

 

For the Purchase of [__] Ordinary Shares

of

INNOVATION BEVERAGE GROUP LIMITED

 

1. Purchase Warrant. THIS CERTIFIES THAT, in
consideration of funds duly paid by or on behalf of EF Hutton, division of Benchmark Investments, LLC (“Holder”), as
registered owner of this Purchase Warrant, Innovation Beverage Group Limited., an Australian public limited company (collectively with
its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being
subsidiaries (the “Company”), Holder is entitled, at any time or from time to time from _______, 2022 [DATE THAT
IS SIX MONTHS FROM THE DATE OF THE COMMENCEMENT OF SALES OF THE PUBLIC SECURITIES IN THIS INITIAL PUBLIC OFFERING] (the “Commencement
Date”), and at or before 5:00 p.m., Eastern time, _______, 2027 [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THIS
OFFERING] (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part,
up to [●][1] ordinary shares, no par value, of the Company
(the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which
banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not
such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action
that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at a price of $___ per Share; provided,
however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase
Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein
specified. The term “Exercise Price” shall mean the initial exercise price of $____ per Share (equal to 120% of the
initial public offering price) or the adjusted exercise price, depending on the context. The term “Effective Date”
shall mean ___________, 2022, the date on which the Registration Statement on Form F-1 (File No. 333-266965) of the Company (“Registration
Statement”) was declared effective by the Securities and Exchange Commission (the “Commission”).

 

2. Exercise.

 

2.1 Exercise Form. In order
to exercise this Purchase Warrant, the exercise form attached hereto must be duly executed and completed and delivered to the Company,
together with this Purchase Warrant and payment of the Exercise Price for the Shares being purchased payable in cash by wire transfer
of immediately available funds to an account designated by the Company or by certified check or official bank check. If the subscription
rights represented hereby shall not be exercised at or before 5:00 p.m., Eastern Time, on the Expiration Date, this Purchase Warrant shall
become and be void without further force or effect, and all rights represented hereby shall cease and expire.

  

[1]
5% of the aggregate number of ordinary shares sold in the Offering (including Option Shares).

 

    

     

    

  

2.2 Cashless Exercise. If
at any time after the Commencement Date there is no effective registration statement registering, or no current prospectus available for,
the resale of the Shares by the Holder, then in lieu of exercising this Purchase Warrant by payment of cash or check payable to the order
of the Company pursuant to Section 2.1 above, Holder may elect to receive the number of Shares equal to the value of this Purchase
Warrant (or the portion thereof being exercised), by surrender of this Purchase Warrant to the Company, together with the exercise form
attached hereto, in which event the Company shall issue to Holder, Shares in accordance with the following formula:

 

	X	=	Y(A-B)	 
	A	 

 

	Where,	 	 	 
	 	X	=	The number of Shares to
    be issued to Holder;
	 	Y	=	The number of Shares for
    which the Purchase Warrant is being exercised;
	 	A	=	The fair market value of
    one Share; and
	 	B	=	The Exercise Price.

 

For purposes of this Section 2.2,
the fair market value of a Share is defined as follows:

 

	 	(i)	if the Company’s ordinary shares is traded on a securities exchange, the value shall be deemed to be the closing price on such exchange on the trading day immediately prior to the exercise form being received by the Company in connection with the exercise of the Purchase Warrant; or
	 	 	 
	 	(ii)	if the Company’s ordinary shares is actively traded over-the-counter, the value shall be deemed to be the closing bid price on the trading day prior to the exercise form being received by the Company in connection with the exercise of the Purchase Warrant; if there is no active public market, the value shall be the fair market value thereof, as determined in good faith by the Company’s Board of Directors.

  

2.3 Legend. If at any time
after the Commencement Date there is no effective registration statement registering, or no current prospectus available for, the resale
of the Shares by the Holder, each certificate for the securities purchased under this Purchase Warrant shall bear a legend as follows
unless such securities have been registered under the Securities Act of 1933, as amended (the “Securities Act”):

 

“THE SECURITIES REPRESENTED BY THIS
CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE
LAW. NEITHER THE SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED FOR SALE, SOLD OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT, OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT AND APPLICABLE
STATE LAW WHICH, IN THE OPINION OF COUNSEL TO THE COMPANY, IS AVAILABLE.”

 

3. Transfer Restrictions.

 

3.1 General Restrictions.
The registered Holder of this Purchase Warrant agrees by his, her or its acceptance hereof, that such Holder will not: (a) sell, transfer,
assign, pledge or hypothecate this Purchase Warrant for a period of one hundred eighty (180) days following the Commencement Date to anyone
other than: (i) EF Hutton, division of Benchmark Investments, LLC (“EF Hutton”) or an underwriter or a selected dealer
participating in the Offering, or (ii) a bona fide officer or partner of EF Hutton or of any such underwriter or selected dealer, in each
case in accordance with FINRA Rule 5110(e)(1), or (b) for a period of one hundred eighty (180) days following the Commencement Date, cause
this Purchase Warrant or the securities issuable hereunder to be the subject of any hedging, short sale, derivative, put or call transaction
that would result in the effective economic disposition of this Purchase Warrant or the securities hereunder, except as provided for in
FINRA Rule 5110(e)(2). On and after 180 days after the Commencement Date, transfers to others may be made subject to compliance with or
exemptions from applicable securities laws. In order to make any permitted assignment, the Holder must deliver to the Company the assignment
form attached hereto duly executed and completed, together with the Purchase Warrant and payment of all transfer taxes, if any, payable
in connection therewith. The Company shall within five (5) business days transfer this Purchase Warrant on the books of the Company and
shall execute and deliver a new Purchase Warrant or Purchase Warrants of like tenor to the appropriate assignee(s) expressly evidencing
the right to purchase the aggregate number of Shares purchasable hereunder or such portion of such number as shall be contemplated by
any such assignment.

 

    A-2

     

    

 

3.2 Restrictions Imposed by
the Securities Act. If at any time after the Commencement Date there is no effective registration statement registering, or no current
prospectus available for, the resale of the Shares by the Holder, the securities evidenced by this Purchase Warrant shall not be transferred
unless and until: (i) the Company has received the opinion of counsel for the Holder that the securities may be transferred pursuant to
an exemption from registration under the Securities Act and applicable state securities laws, the availability of which is established
to the reasonable satisfaction of the Company (the Company hereby agreeing that the opinion of Carmel, Milazzo & Feil LLP shall be
deemed satisfactory evidence of the availability of an exemption), or (ii) a registration statement or a post-effective amendment to the
Registration Statement relating to the offer and sale of such securities has been filed by the Company and declared effective by the Commission
and compliance with applicable state securities law has been established.

 

4 Registration Rights.

 

4.1 Demand Registration.

 

4.1.1 Grant of Right. The
Company, upon written demand (a “Demand Notice”) of the Holders of at least 51% of the Purchase Warrants and/or the
underlying Shares, agrees to register, on one (1) occasion, all or any portion of Shares for which the Purchase Warrant is exercisable
(collectively, the “Registrable Securities”). On such occasion, the Company will file a registration statement with
the Commission covering the Registrable Securities within sixty (60) days after receipt of a Demand Notice and use its reasonable best
efforts to have the registration statement declared effective promptly thereafter, subject to compliance with review by the Commission;
provided, however, that the Company shall not be required to comply with a Demand Notice if the Company has filed a registration
statement with respect to which the Holder is entitled to piggyback registration rights pursuant to Section 4.2 hereof and either:
(i) the Holder has elected to participate in the offering covered by such registration statement or (ii) if such registration statement
relates to an underwritten primary offering of securities of the Company, until the offering covered by such registration statement has
been withdrawn or until thirty (30) days after such offering is consummated. The Company covenants and agrees to give written notice of
its receipt of any Demand Notice by any Holders to all other registered Holders of the Purchase Warrants and/or the Registrable Securities
within ten (10) days after the date of the receipt of any such Demand Notice. Notwithstanding anything to the contrary, the obligations
of the Company pursuant to this Section 4.1 shall not be applicable so long as the Company’s Registration Statement on Form
F-1 (File No. 333-266965) covering the Registrable Securities remains effective and such demand registration right will have a duration of 5 (five) years
from the commencement of sales of the public offering.

 

4.1.2 Terms. The Company
shall bear all fees and expenses attendant to the registration of the Registrable Securities pursuant to Section 4.1.1, but the
Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders to represent them
in connection with the sale of the Registrable Securities. The Company agrees to use its reasonable best efforts to cause the filings
required herein to become effective promptly and to qualify or register the Registrable Securities in such states of the Unites States
of America or such foreign jurisdictions as may be reasonably requested by the Holders; provided, however, that in no event
shall the Company be required to register the Registrable Securities in such states or jurisdictions in which such registration would
cause: (i) the Company to be obligated to register or license to do business in such state or jurisdiction or submit to general service
of process therein, or (ii) the principal stockholders of the Company to be obligated to escrow their shares of capital stock of the Company.
The Company shall cause any registration statement filed pursuant to the demand right granted under Section 4.1.1 to remain effective
for a period of at least twelve (12) consecutive months after the date that the Holders of the Registrable Securities covered by such
registration statement are first given the opportunity to sell all of such securities. The Holders shall only use the prospectuses provided
by the Company to sell the shares covered by such registration statement and will immediately cease to use any prospectus furnished by
the Company if the Company advises the Holder that such prospectus may no longer be used due to a material misstatement or omission. Notwithstanding
the provisions of this Section 4.1.2, the Holder shall be entitled to a demand registration under this Section 4.1.2 on
only one (1) occasion in accordance with FINRA Rule 5110(g)(8)(B) and such demand registration right shall terminate on the third anniversary
of the Effective Date in accordance with FINRA Rule 5110(g)(8)(C).

 

    A-3

     

    

 

4.2 “Piggy-Back”
Registration.

 

4.2.1 Grant of Rights. In
addition to the demand right of registration described in Section 4.1 hereof, the Holder shall have the right, for a period of
no more than seven (7) years from the Effective Date in accordance with FINRA Rule 5110(g)(8)(D), to include the Registrable Securities
as part of any other registration of securities filed by the Company (other than in connection with a transaction contemplated by Rule
145(a) promulgated under the Securities Act or pursuant to Form S-8 or Form S-4; equivalent form); provided, however, that
if, solely in connection with any primary underwritten public offering for the account of the Company, the managing underwriter(s) thereof
shall, in its reasonable discretion, impose a limitation on the number of Registrable Securities which may be included in the Registration
Statement because, in such underwriter(s)’ judgment, marketing or other factors dictate such limitation is necessary to facilitate
public distribution, then the Company shall be obligated to include in such Registration Statement only such limited portion of the Registrable
Securities with respect to which the Holder requested inclusion hereunder as the underwriter shall reasonably permit. Any exclusion of
Registrable Securities shall be made pro rata among the Holders seeking to include Registrable Securities in proportion to the number
of Registrable Securities sought to be included by such Holders; provided, however, that the Company shall not exclude any
Registrable Securities unless the Company has first excluded all outstanding securities, the holders of which are not entitled to inclusion
of such securities in such Registration Statement or are not entitled to pro rata inclusion with the Registrable Securities. Notwithstanding
anything to the contrary, the obligations of the Company pursuant to this Section 4.2 shall not be applicable so long as the Company’s
Registration Statement on Form F-1 (File No. 333-266965) covering the Registrable Securities remains effective.

 

4.2.2 Terms. The Company
shall bear all fees and expenses attendant to registering the Registrable Securities pursuant to Section 4.2.1 hereof, but the
Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders to represent them
in connection with the sale of the Registrable Securities. In the event of such a proposed registration, the Company shall furnish the
then Holders of outstanding Registrable Securities with not less than thirty (30) days’ written notice prior to the proposed date
of filing of such registration statement. Such notice to the Holders shall continue to be given for each registration statement filed
by the Company until such time as all of the Registrable Securities have been sold by the Holder. The holders of the Registrable Securities
shall exercise the “piggy-back” rights provided for herein by giving written notice within ten (10) days of the receipt of
the Company’s notice of its intention to file a registration statement. Except as otherwise provided in this Purchase Warrant, there
shall be no limit on the number of times the Holder may request registration under this Section 4.2.2; provided, however,
that such registration rights shall terminate on the third (3rd) anniversary of the Commencement Date.

 

4.3 General Terms.

 

4.3.1 Indemnification. The
Company shall indemnify the Holders of the Registrable Securities to be sold pursuant to any registration statement hereunder and each
person, if any, who controls such Holders within the meaning of section 15 of the Securities Act or section 20(a) of the Securities Exchange
Act of 1934, as amended (“Exchange Act”), against all loss, claim, damage, expense or liability (including all reasonable
attorneys’ fees and other expenses reasonably incurred in investigating, preparing or defending against any claim whatsoever) to
which any of them may become subject under the Securities Act, the Exchange Act or otherwise, arising from such registration statement
but only to the same extent and with the same effect as the provisions pursuant to which the Company has agreed to indemnify the Underwriters
contained in Section 5.1 of the Underwriting Agreement between the Underwriters (as defined therein) and the Company, dated ___________,
2022 with respect to the Company’s initial public offering of the Shares. The Holders of the Registrable Securities to be sold pursuant
to such registration statement, and their successors and assigns, shall severally, and not jointly, indemnify the Company, against all
loss, claim, damage, expense or liability (including all reasonable attorneys’ fees and other expenses reasonably incurred in investigating,
preparing or defending against any claim whatsoever) to which they may become subject under the Securities Act, the Exchange Act or otherwise,
arising from information furnished by or on behalf of such Holders, or their successors or assigns, in writing, for specific inclusion
in such registration statement to the same extent and with the same effect as the provisions contained in Section 5.2 of the Underwriting
Agreement pursuant to which the Underwriters have agreed to indemnify the Company.

 

    A-4

     

    

 

4.3.2 Exercise of Purchase Warrants.
Nothing contained in this Purchase Warrant shall be construed as requiring the Holders to exercise their Purchase Warrants prior to or
after the initial filing of any registration statement or the effectiveness thereof.

 

4.3.3 Documents Delivered to
Holders. The Company shall furnish to each Holder participating in any of the foregoing offerings and to each underwriter of any such
offering, if any, a signed counterpart, addressed to such Holder or underwriter, of: (i) an opinion of counsel to the Company, dated the
effective date of such registration statement (and, if such registration includes an underwritten public offering, an opinion dated the
date of the closing under any underwriting agreement related thereto), and (ii) a “cold comfort” letter dated the effective
date of such registration statement (and, if such registration includes an underwritten public offering, a letter dated the date of the
closing under the underwriting agreement) signed by the independent registered public accounting firm which has issued a report on the
Company’s financial statements included in such registration statement, in each case covering substantially the same matters with
respect to such registration statement (and the prospectus included therein) and, in the case of such accountants’ letter, with
respect to events subsequent to the date of such financial statements, as are customarily covered in opinions of issuer’s counsel
and in accountants’ letters delivered to underwriters in underwritten public offerings of securities. The Company shall also deliver
promptly to each Holder participating in the offering requesting the correspondence and memoranda described below and to the managing
underwriter, if any, copies of all correspondence between the Commission and the Company, its counsel or auditor and all memoranda relating
to discussions with the Commission or its staff with respect to the registration statement and permit each Holder and underwriter to do
such investigation, upon reasonable advance notice, with respect to information contained in or omitted from the registration statement
as it deems reasonably necessary to comply with applicable securities laws or rules of FINRA. Such investigation shall include access
to books, records and properties and opportunities to discuss the business of the Company with its officers and independent auditor, all
to such reasonable extent and at such reasonable times as any such Holder shall reasonably request.

 

4.3.4 Underwriting Agreement.
The Company shall enter into an underwriting agreement with the managing underwriter(s), if any, selected by any Holders whose Registrable
Securities are being registered pursuant to this Section 4, which managing underwriter shall be reasonably satisfactory to the
Company. Such agreement shall be reasonably satisfactory in form and substance to the Company, each Holder and such managing underwriters,
and shall contain such representations, warranties and covenants by the Company and such other terms as are customarily contained in agreements
of that type used by the managing underwriter. The Holders shall be parties to any underwriting agreement relating to an underwritten
sale of their Registrable Securities and may, at their option, require that any or all the representations, warranties and covenants of
the Company to or for the benefit of such underwriters shall also be made to and for the benefit of such Holders. Such Holders shall not
be required to make any representations or warranties to or agreements with the Company or the underwriters except as they may relate
to such Holders, their Shares, and their intended methods of distribution.

 

4.3.5 Documents to be Delivered
by Holders. Each of the Holders participating in any of the foregoing offerings shall furnish to the Company a completed and executed
questionnaire provided by the Company requesting information customarily sought of selling security holders.

 

4.3.6 Damages. Should the
registration or the effectiveness thereof required by Sections 4.1 and 4.2 hereof be delayed by the Company or the Company otherwise fails
to comply with such provisions, the Holders shall, in addition to any other legal or other relief available to the Holders, be entitled
to obtain specific performance or other equitable (including injunctive) relief against the threatened breach of such provisions or the
continuation of any such breach, without the necessity of proving actual damages and without the necessity of posting bond or other security.

 

4.4 Termination of Registration
Rights. The registration rights afforded to the Holders under this Section 4 shall terminate on the earliest date when all
Registrable Securities of such Holder either: (i) have been publicly sold by such Holder pursuant to a Registration Statement, (ii) have
been covered by an effective Registration Statement on Form F-1 or Form S-3 (or successor form), which may be kept effective as an evergreen
Registration Statement, or (iii) may be sold by the Holder (including on a cashless basis) within a 90-day period without registration
pursuant to Rule 144 or consistent with applicable SEC interpretive guidance (including CD&I No. 201.04 (April 2, 2007) or similar
interpretive guidance).

 

    A-5

     

    

 

5. New Purchase Warrants to be Issued.

 

5.1 Partial Exercise or Transfer.
Subject to the restrictions in Section 3 hereof, this Purchase Warrant may be exercised or assigned in whole or in part. In the
event of the exercise or assignment hereof in part only, upon surrender of this Purchase Warrant for cancellation, together with the duly
executed exercise or assignment form and funds sufficient to pay any Exercise Price and/or transfer tax if exercised pursuant to Section
2.1 hereto, the Company shall cause to be delivered to the Holder without charge a new Purchase Warrant of like tenor to this Purchase
Warrant in the name of the Holder evidencing the right of the Holder to purchase the number of Shares purchasable hereunder as to which
this Purchase Warrant has not been exercised or assigned.

 

5.2 Lost Certificate. Upon
receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of this Purchase Warrant and of reasonably
satisfactory indemnification or the posting of a bond, the Company shall execute and deliver a new Purchase Warrant of like tenor and
date. Any such new Purchase Warrant executed and delivered as a result of such loss, theft, mutilation or destruction shall constitute
a substitute contractual obligation on the part of the Company.

 

6. Adjustments.

 

6.1 Adjustments to Exercise
Price and Number of Securities. The Exercise Price and the number of Shares underlying the Purchase Warrant shall be subject to adjustment
from time to time as hereinafter set forth:

 

6.1.1 Share Dividends; Split
Ups. If, after the date hereof, and subject to the provisions of Section 6.3 below, the number of outstanding Shares is increased
by a stock dividend payable in Shares or by a split up of Shares or other similar event, then, on the effective day thereof, the number
of Shares purchasable hereunder shall be increased in proportion to such increase in outstanding Shares, and the Exercise Price shall
be proportionately decreased.

 

6.1.2 Aggregation of Shares.
If, after the date hereof, and subject to the provisions of Section 6.3 below, the number of outstanding Shares is decreased by
a consolidation, combination or reclassification of Shares or other similar event, then, on the effective date thereof, the number of
Shares purchasable hereunder shall be decreased in proportion to such decrease in outstanding Shares, and the Exercise Price shall be
proportionately increased.

 

6.1.3 Replacement of Securities
upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding Shares or a variation of share capital
of the Company, other than a change covered by Section 6.1.1 or 6.1.2 hereof or that solely affects the par value of such Shares, or in
the case of any share reconstruction or amalgamation or consolidation of the Company with or into another corporation (other than a consolidation
or share reconstruction or amalgamation in which the Company is the continuing corporation and that does not result in any reclassification
or reorganization of the outstanding Shares), or in the case of any sale or conveyance to another corporation or entity of the property
of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the Holder of this Purchase
Warrant shall have the right thereafter (until the expiration of the right of exercise of this Purchase Warrant) to receive upon the exercise
hereof, for the same aggregate Exercise Price payable hereunder immediately prior to such event, the kind and amount of shares of stock
or other securities or property (including cash) receivable upon such reclassification, reorganization, share reconstruction or amalgamation,
or consolidation, or upon a dissolution following any such sale or transfer, by a Holder of the number of Shares of the Company obtainable
upon exercise of this Purchase Warrant immediately prior to such event; and if any reclassification also results in a change in Shares
covered by Section 6.1.1 or 6.1.2, then such adjustment shall be made pursuant to Sections 6.1.1, 6.1.2 and this Section 6.1.3. The provisions
of this Section 6.1.3 shall similarly apply to successive reclassifications, reorganizations, share reconstructions or amalgamations,
or consolidations, sales or other transfers.

 

6.1.4 Changes in Form of Purchase
Warrant. This form of Purchase Warrant need not be changed because of any change pursuant to this Section 6.1, and Purchase
Warrants issued after such change may state the same Exercise Price and the same number of Shares as are stated in the Purchase Warrants
initially issued pursuant to this Agreement. The acceptance by any Holder of the issuance of new Purchase Warrants reflecting a required
or permissive change shall not be deemed to waive any rights to an adjustment occurring after the Commencement Date or the computation
thereof.

 

    A-6

     

    

 

6.2 Substitute Purchase Warrant.
In case of any consolidation of the Company with, or share reconstruction or amalgamation of the Company with or into, another corporation
(other than a consolidation or share reconstruction or amalgamation which does not result in any reclassification or change of the outstanding
Shares), the corporation formed by such consolidation or share reconstruction or amalgamation shall execute and deliver to the Holder
a supplemental Purchase Warrant providing that the holder of each Purchase Warrant then outstanding or to be outstanding shall have the
right thereafter (until the stated expiration of such Purchase Warrant) to receive, upon exercise of such Purchase Warrant, the kind and
amount of shares of stock and other securities and property receivable upon such consolidation or share reconstruction or amalgamation,
by a holder of the number of Shares for which such Purchase Warrant might have been exercised immediately prior to such consolidation,
share reconstruction or amalgamation, sale or transfer. Such supplemental Purchase Warrant shall provide for adjustments which shall be
identical to the adjustments provided for in this Section 6. The above provision of this Section shall similarly apply to successive
consolidations or share reconstructions or amalgamations.

 

6.3 Elimination of Fractional
Interests. The Company shall not be required to issue fractions of Shares upon the exercise of the Purchase Warrant, nor shall it
be required to issue scrip or pay cash in lieu of any fractional interests, it being the intent of the parties that all fractional interests
shall be eliminated by rounding any fraction up or down, as the case may be, to the nearest whole number of Shares or other securities,
properties or rights.

 

7. Reservation and Listing. The Company shall
at all times reserve and keep available out of its authorized Shares, solely for the purpose of issuance upon exercise of the Purchase
Warrants, such number of Shares or other securities, properties or rights as shall be issuable upon the exercise thereof. The Company
covenants and agrees that, upon exercise of the Purchase Warrants and payment of the Exercise Price therefor, in accordance with the terms
hereby, all Shares and other securities issuable upon such exercise shall be duly and validly issued, fully paid and non-assessable and
not subject to preemptive rights of any stockholder. As long as the Purchase Warrants shall be outstanding, the Company shall use its
commercially reasonable efforts to list (subject to official notice of issuance) on all national securities exchanges (or, if applicable,
on the OTC Bulletin Board or any successor trading market) on which the Shares issued to the public in the Offering may then be listed
and/or quoted.

 

8. Certain Notice Requirements.

 

8.1 Holder’s Right to
Receive Notice. Nothing herein shall be construed as conferring upon the Holders the right to vote or consent or to receive notice
as a stockholder for the election of directors or any other matter, or as having any rights whatsoever as a stockholder of the Company.
If, however, at any time prior to the expiration of the Purchase Warrants and their exercise, any of the events described in Section
8.2 shall occur, then, in one or more of said events, the Company shall give written notice of such event at least fifteen (15) days
prior to the date fixed as a record date or the date of closing the transfer books for the determination of the stockholders entitled
to such dividend, distribution, conversion or exchange of securities or subscription rights, or entitled to vote on such proposed dissolution,
liquidation, winding up or sale. Such notice shall specify such record date or the date of the closing of the transfer books, as the case
may be. Notwithstanding the foregoing, the Company shall deliver to each Holder a copy of each notice given to the other stockholders
of the Company at the same time and in the same manner that such notice is given to the stockholders.

 

8.2 Events Requiring Notice.
The Company shall be required to give the notice described in this Section 8 upon one or more of the following events: (i) if the
Company shall take a record of the holders of its Shares for the purpose of entitling them to receive a dividend or distribution payable
otherwise than in cash, or a cash dividend or distribution payable otherwise than out of retained earnings, as indicated by the accounting
treatment of such dividend or distribution on the books of the Company; (ii) the Company shall offer to all the holders of its Shares
any additional shares of capital stock of the Company or securities convertible into or exchangeable for shares of capital stock of the
Company, or any option, right or warrant to subscribe therefor; or (iii) a dissolution, liquidation or winding up of the Company (other
than in connection with a consolidation or share reconstruction or amalgamation) or a sale of all or substantially all of its property,
assets and business shall be proposed.

 

8.3 Notice of Change in Exercise
Price. The Company shall, promptly after an event requiring a change in the Exercise Price pursuant to Section 6 hereof, send
notice to the Holders of such event and change (“Price Notice”). The Price Notice shall describe the event causing
the change and the method of calculating same and shall be certified as being true and accurate by the Company’s Chief Financial
Officer.

 

    A-7

     

    

 

8.4 Transmittal of Notices.
All notices, requests, consents and other communications under this Purchase Warrant shall be in writing and shall be deemed to have been
duly made when hand delivered or mailed by express mail or private courier service: (i) if to the registered Holder of the Purchase Warrant,
to the address of such Holder as shown on the books of the Company, or (ii) if to the Company, to following address or to such other address
as the Company may designate by notice to the Holders:

 

If to the Holder:

 

EF Hutton, division of Benchmark
Investments, LLC

590 Madison Avenue, 39th Floor

New York, New York 10022

Attn: Mr. Joseph T. Rallo, Head of Investment Banking

Fax:

Email: jrallo@efhuttongroupcm.com

 

with a copy (which shall not constitute
notice) to:

 

Ross Carmel, Esq.

Carmel, Milazzo & Feil LLP

55 West 39th Street, 18th
Floor

New York, New York 10018

Fax: (646) 838-1314

Email: rcarmel@cmfllp.com

 

If to the Company:

 

Innovation Beverage Group Limited

29 Anvil Rd

Seven Hills, NSW 2147, Australia

Attn: Mr. Dean Huge

Email: dean@innovationbev.com

 

with a copy (which shall not constitute
notice) to:

 

Darrin Ocasio, Esq

Sichenzia Ross Ference LLP

1185 Avenue of the Americas, 31th
Floor

New York, NY 10036

Email: dmocasio@srf.law

 

9. Miscellaneous.

 

9.1 Amendments. The Company
and EF Hutton may from time to time supplement or amend this Purchase Warrant without the approval of any of the Holders in order to cure
any ambiguity, to correct or supplement any provision contained herein that may be defective or inconsistent with any other provisions
herein, or to make any other provisions in regard to matters or questions arising hereunder that the Company and EF Hutton may deem necessary
or desirable and that the Company and EF Hutton deem shall not adversely affect the interest of the Holders. All other modifications or
amendments shall require the written consent of and be signed by the party against whom enforcement of the modification or amendment is
sought.

 

9.2 Headings. The headings
contained herein are for the sole purpose of convenience of reference and shall not in any way limit or affect the meaning or interpretation
of any of the terms or provisions of this Purchase Warrant.

 

    A-8

     

    

 

9.3 Entire Agreement. This
Purchase Warrant (together with the other agreements and documents being delivered pursuant to or in connection with this Purchase Warrant)
constitutes the entire agreement of the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and
understandings of the parties, oral and written, with respect to the subject matter hereof.

 

9.4 Binding Effect. This
Purchase Warrant shall inure solely to the benefit of and shall be binding upon, the Holder and the Company and their permitted assignees,
respective successors, legal representative and assigns, and no other person shall have or be construed to have any legal or equitable
right, remedy or claim under or in respect of or by virtue of this Purchase Warrant or any provisions herein contained.

 

9.5 Governing Law; Submission
to Jurisdiction; Trial by Jury. This Purchase Warrant shall be governed by and construed in accordance with the law of the State of
New York. The Company hereby agrees that any action, proceeding or claim against it arising out of, or relating in any way to this Purchase
Warrant shall be brought and enforced in the Supreme Court of the State of New York sitting in the County of New York, or in the United
States District Court for the Southern District of New York, and irrevocably submits to the jurisdiction of such courts and the appellate
courts therefrom, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and that
such courts represent an inconvenient forum. Any process or summons to be served upon the Company may be served by transmitting a copy
thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in Section
8 hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the Company in any action, proceeding
or claim. The Company and the Holder agree that the prevailing party(ies) in any such action shall be entitled to recover from the other
party(ies) all of its reasonable attorneys’ fees and expenses relating to such action or proceeding and/or incurred in connection
with the preparation therefor. The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders
and affiliates) and the Holder hereby irrevocably waive, to the fullest extent permitted by applicable law, any and all right to trial
by jury in any legal proceeding arising out of or relating to this Purchase Warrant or the transactions contemplated hereby.

 

9.6 Waiver, etc. The failure
of the Company or the Holder to at any time enforce any of the provisions of this Purchase Warrant shall not be deemed or construed to
be a waiver of any such provision, nor to in any way affect the validity of this Purchase Warrant or any provision hereof or the right
of the Company or any Holder to thereafter enforce each and every provision of this Purchase Warrant. No waiver of any breach, non-compliance
or non-fulfillment of any of the provisions of this Purchase Warrant shall be effective unless set forth in a written instrument executed
by the party or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance or
non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.

 

9.7 Execution in Counterparts.
This Purchase Warrant may be executed in one or more counterparts, and by the different parties hereto in separate counterparts, each
of which shall be deemed to be an original, but all of which taken together shall constitute one and the same agreement, and shall become
effective when one or more counterparts has been signed by each of the parties hereto and delivered to each of the other parties hereto.
Such counterparts may be delivered by facsimile transmission or other electronic transmission.

 

9.8 Exchange Agreement.
As a condition of the Holder’s receipt and acceptance of this Purchase Warrant, Holder agrees that, at any time prior to the complete
exercise of this Purchase Warrant by Holder, if the Company and EF Hutton enter into an agreement (“Exchange Agreement”)
pursuant to which they agree that all outstanding Purchase Warrants will be exchanged for securities or cash or a combination of both,
then Holder shall agree to such exchange and become a party to the Exchange Agreement.

 

[Signature Page Follows]

 

    A-9

     

    

 

IN WITNESS WHEREOF, the
Company has caused this Purchase Warrant to be signed by its duly authorized officer as of the ____ day of _______, 2022.

 

	 	INNOVATION BEVERAGE GROUP LIMITED
	 	 
	 	By:	 
	 	Name:	 Dean Huge
	 	Title: 	Chief Executive Officer

  

    A-10

     

    

 

[Form to be used to exercise Purchase Warrant]

 

Date: __________, 20___

 

The undersigned hereby elects irrevocably
to exercise the Purchase Warrant for ______ Ordinary Shares (the “Shares”), of , Innovation Beverage Group Limited.,
an Australian public limited company (the “Company”), and hereby makes payment of $____ (at the rate of $____ per Share)
in payment of the Exercise Price pursuant thereto. Please issue the Shares as to which this Purchase Warrant is exercised in accordance
with the instructions given below and, if applicable, a new Purchase Warrant representing the number of Shares for which this Purchase
Warrant has not been exercised.

 

or

 

The undersigned hereby elects irrevocably
to convert its right to purchase Shares of the Company under the Purchase Warrant for ______ Shares, as determined in accordance with
the following formula:

  

	 	X	=	Y(A-B)

     

    A
	 

     

     

 

	Where,	 	 	 
	 	X	=	The number of Shares
    to be issued to Holder;
	 	Y	=	The number of Shares for which the Purchase Warrant
    is being exercised;
	 	A	=	The fair market value of one Share which is equal to
    $_____; and
	 	B	=	The Exercise Price which is equal to $______ per share

  

The undersigned agrees and acknowledges
that the calculation set forth above is subject to confirmation by the Company and any disagreement with respect to the calculation shall
be resolved by the Company in its sole discretion.

 

Please issue the Shares as to which
this Purchase Warrant is exercised in accordance with the instructions given below and, if applicable, a new Purchase Warrant representing
the number of Shares for which this Purchase Warrant has not been exercised.

 

Signature _______________________________________

 

Signature Guaranteed ______________________________

 

INSTRUCTIONS FOR REGISTRATION OF SECURITIES

  

	Name:
    	 	 
	 	(Print
    in Block Letters)	 

 

	Address:
    	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 

  

NOTICE: The signature to this form
must correspond with the name as written upon the face of the Purchase Warrant without alteration or enlargement or any change whatsoever,
and must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm having membership on a registered national
securities exchange.

 

[Form to be used to assign Purchase Warrant]

 

    A-11

     

    

 

ASSIGNMENT

 

(To be executed by the registered Holder to effect a transfer of the within
Purchase Warrant):

 

FOR VALUE RECEIVED, __________________ does hereby
sell, assign and transfer unto______________ the right to purchase _______________ ordinary shares (the “Shares”) of
Innovation Beverage Group Limited., (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed
or described in the Registration Statement as being subsidiaries (the “Company”), evidenced by the Purchase Warrant
and does hereby authorize the Company to transfer such right on the books of the Company.

 

Dated: __________, 20__

  

	Signature
    	 	 

 

	Signature
    Guaranteed 	 	 

  

NOTICE: The signature to this form must correspond
with the name as written upon the face of the within Purchase Warrant without alteration or enlargement or any change whatsoever, and
must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm having membership on a registered national
securities exchange.

  

A-12EXHIBIT 10.20

 

Form of Lock-Up Agreement

 

for

 

Officers, Directors, and Holder(s)
of more than 5% of Ordinary Shares

 

[●], 2022

 

EF HUTTON,

division of Benchmark Investments, LLC

as Representative of the several Underwriters named on Schedule
1 attached hereto

590 Madison Avenue, 39th Floor

New York, New York 10022

 

Ladies and Gentlemen:

 

The undersigned,
an officer, director and/or holder of more than [●] shares of ordinary shares (the “Ordinary Shares”),
or rights to acquire more than [●] shares of Ordinary Shares (the “Shares”) of Innovation Beverage Group
Limited (the “Company”), understands that you are the representative (the “Representative”)
of several underwriters (collectively, the “Underwriters”), named or to be named in the final form of Schedule 1
to the underwriting agreement (the “Underwriting Agreement”) to be entered into among the Underwriters and the
Company, providing for the public offering (the “Public Offering”) of securities of the Company (the “Securities”)
pursuant to a registration statement (No. 333-[●]) filed (the “Registration Statement”) with the U.S.
Securities and Exchange Commission (the “SEC”) on [●].

 

In consideration
of the Underwriters’ agreement to enter into the Underwriting Agreement and to proceed with the Public Offering of the Securities,
and for other good and valuable consideration, receipt of which is hereby acknowledged, the Undersigned hereby agrees, for the
benefit of the Company, the Representative and the other Underwriters that, without the prior written consent of the Representative,
the Undersigned will not, during the period commencing on the date of this Lock-up Agreement and continuing and including the date
that is one-hundred and eighty (180) days after the closing of the Public Offering (the “Lock-Up Period”), unless
otherwise provided herein, directly or indirectly (a) offer, sell, agree to offer or sell, solicit offers to purchase, grant any
call option or purchase any put option with respect to, pledge, encumber, assign, borrow or otherwise dispose of (each a “Transfer”)
any Relevant Security (as defined below) or otherwise publicly disclose the intention to do so, or (b) establish or increase any
“put equivalent position” or liquidate or decrease any “call equivalent position” with respect to any Relevant
Security (in each case within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), and the rules and regulations thereunder) with respect to any Relevant Security or otherwise enter into any swap,
derivative or other transaction or arrangement that Transfers to another, in whole or in part, any economic consequence of ownership
of a Relevant Security, whether or not such transaction is to be settled by the delivery of Relevant Securities, other securities,
cash or other consideration, or otherwise publicly disclose the intention to do so. As used herein, the term “Relevant
Security” means any Shares or any other security of the Company or any other entity that is convertible into, or exercisable
or exchangeable for, Shares, in each case owned beneficially or otherwise by the Undersigned on the date of closing of the Public
Offering or acquired by the Undersigned during the Lock-Up Period.

 

The restrictions
in the foregoing paragraph shall not apply to (a) any exercise (including a cashless exercise or broker-assisted exercise and payment
of tax obligations), vesting or settlement, as applicable, by the Undersigned of options to purchase Shares or other equity awards
pursuant to any stock incentive plan or stock purchase plan of the Company; provided that any Shares received by the Undersigned
upon such exercise, conversion or exchange will be subject to the Lock-Up Period, (b) any establishment of a trading plan pursuant
to Rule 10b5-1 under the Exchange Act for the Transfer of Shares (a “Trading Plan”); provided that (i) the Trading
Plan shall not provide for or permit any Transfers, sales or other dispositions of Shares during the Lock-Up Period and (ii) the
Trading Plan would not require any filing under Section 16(a) of the Exchange Act and no such filing is voluntarily made, (c) any
Transfer of Shares acquired in open market transactions following the closing of the Public Offering, provided the Transfer would
not require any filing under Section 16(a) of the Exchange Act and no such filing is voluntarily made, (d) the Transfer of the
Undersigned’s Shares or any security convertible into or exercisable or exchangeable for Ordinary Shares to the Company in
connection with the termination of the Undersigned’s employment with the Company or pursuant to contractual arrangements
under which the Company has the option to repurchase such shares,

 

    	 

    	 

    

 

provided that no filing by any party under the Exchange Act shall
be required or shall be made voluntarily within 45 days after the date the Undersigned ceases to provide services to the Company,
and after such 45th day, if the Undersigned is required to file a report under the Exchange Act reporting a reduction
in beneficial ownership of shares of Ordinary Shares during the Lock-Up Period, the Undersigned shall indicate in the footnotes
thereto that the filing relates to the termination of the Undersigned’s employment, and no other public announcement shall
be made voluntarily in connection with such transfer (other than the filing on a Form 5 made after the expiration of the Lock-Up
Period), (e) the conversion of the outstanding securities into Shares, provided that any such Shares received upon such conversion
shall be subject to the restrictions on Transfer set forth in this Lock-Up Agreement, or (f) the Transfer of Shares or any security
convertible into or exercisable or exchangeable for Shares pursuant to a bona fide third-party tender offer for securities of the
Company, merger, consolidation or other similar transaction that is approved by the disinterested members of the board of directors
of the Company, made to all holders of Ordinary Shares involving a change of control (as defined below), provided that all of the
Undersigned’s Relevant Securities subject to this Lock-Up Agreement shall remain subject to the restrictions herein. For
purposes of this Lock-Up Agreement, “change of control” means any bona fide third party tender offer, merger,
consolidation or other similar transaction, in one transaction or a series of related transactions, the result of which is that
any “person” (as defined in Section 13(d)(3) of the Exchange Act), or group of affiliated persons, other than
the Company, becomes the beneficial owner (as defined in Rules 13d-3 and 13d-5 of the Exchange Act) of 50% or more of the total
voting power of the voting stock of the Company (or the surviving entity).

 

In addition, the
Undersigned further agrees that, except for the Registration Statement or any registration statement on Form S-8, during the Lock-Up
Period, the Undersigned will not, without the prior written consent of the Representative: (a) file or participate in the filing
with the SEC any registration statement or circulate or participate in the circulation of any preliminary or final prospectus or
other disclosure documents, in each case with respect to any proposed offering or sale of a Relevant Security beneficially owned
by the Undersigned, or (b) exercise any rights the Undersigned may have to require registration with the SEC of any proposed offering
or sale of a Relevant Security beneficially owned by the Undersigned.

 

In furtherance of
the Undersigned’s obligations hereunder, the Undersigned hereby authorizes the Company during the Lock-Up Period to cause
the transfer agent for the Relevant Securities to decline to Transfer, and to note stop transfer restrictions on the stock register
and other records relating to, Relevant Securities for which the Undersigned is the record owner and the Transfer of which would
be a violation of this Lock-Up Agreement and, in the case of the Relevant Securities for which the Undersigned is the beneficial
owner but not the record owner, the Undersigned agrees that during the Lock-Up Period it will use its reasonable best efforts to
cause the record owner to authorize the Company to cause the relevant transfer agent to decline to transfer, and to note stop transfer
restrictions on the stock register and other records relating to such Relevant Securities to the extent such transfer would be
a violation of this Lock-Up Agreement.

 

Notwithstanding the
foregoing or anything contained herein to the contrary, the Undersigned may transfer the Undersigned’s Relevant Securities
without the prior written consent of the Representative:

 

    	 

    	 

    

 

	 	(i)	as a bona fide gift or gifts;
	 	 	 
	 	(ii)	To any immediate family member of the Undersigned, or to any trust, partnership, limited liability company, or other legal entity commonly used for estate planning purposes which are established for the direct or indirect benefit of the Undersigned or a member or members of the immediate family of the Undersigned;
	 	 	 
	 	(iii)	if the Undersigned is a corporation, partnership, limited liability company, trust or other business entity, (1) to another corporation, partnership, limited liability company, trust, or other business entity that is a direct or indirect Affiliate (as defined in Rule 405 under the Securities Act of 1933, as amended) of the Undersigned, (2) to partners, limited liability company members or stockholders of the Undersigned or holders of similar equity interests in the Undersigned, or (3) in connection with a sale, merger or transfer of all or substantially all of the assets of the Undersigned or any other change of control of the Undersigned, not undertaken for the purpose of avoiding the restrictions imposed by this Lock-Up Agreement;
	 	 	 
	 	(iv)	if the Undersigned is a trust, to the trustee or beneficiary of such trust or to the estate of a beneficiary of such trust;
	 	 	 
	 	(v)	by testate or intestate succession;
	 	 	 
	 	(vi)	by operation of law, such as pursuant to a qualified domestic order or in connection with a divorce settlement;
	 	 	 
	 	(vii)	pursuant to the Underwriting Agreement;
	 	 	 
	 	(viii)	the withholder of Shares by, or surrender of Shares to, the Company pursuant to a “net” or “cashless” exercise or settlement feature to cover taxes due upon or the consideration required in connection with the exercise of securities issued under an equity incentive plan or stock purchase plan of the Company; or
	 	 	 
	 	(ix)	to a charity or educational institution;

 

provided, in the case of clauses
(i)-(vi), that (A) such transfer shall not involve a disposition for value, (B) the transferee agrees in writing with the Underwriters
and the Company to be bound by the terms of this Lock-Up Agreement, and (C) such transfer would not require any filing under Section
16(a) of the Exchange Act and no such filing is voluntarily made.

 

For purposes of this
Lock-Up Agreement, “immediate family” shall mean any relationship by blood, marriage, or adoption, not more
remote than the first cousin.

 

If the Undersigned
is an officer or director of the Company, (i) the Representative agrees that, at least three business days before the effective
date of any release or waiver of the foregoing restrictions in connection with a Transfer of Shares, the Representative will notify
the Company of the impending release or waiver and (ii) the Company has agreed in the Underwriting Agreement to announce the impending
release or waiver by press release as set forth in Exhibit C through a major news service at least two business days before the
effective date of the release or waiver. Any release or waiver granted by the Representative hereunder to any such officer or director
shall only be effective two business days after the publication date of such press release. The provisions of this paragraph will
not apply if (a) the release or waiver is effected solely to permit a transfer not for consideration and (b) the transferee has
agreed in writing to be bound by the same terms described in this Lock-Up Agreement to the extent and for the duration that such
terms remain in effect at the time of the transfer.

 

The Undersigned,
whether or not participating in the Public Offering, understands that the Underwriters and the Company are entering into the Underwriting
Agreement and proceeding with the Public Offering in reliance upon this Lock-Up Agreement.

 

The Undersigned hereby
represents and warrants that the Undersigned has full power and authority to enter into this Lock-Up Agreement and that this Lock-Up
Agreement has been duly authorized (if the Undersigned is not a natural person) and constitutes the legal, valid, and binding obligation
of the Undersigned, enforceable in accordance with its terms. Upon request, the Undersigned will execute any additional documents
necessary in connection with the enforcement hereof. Any obligations of the Undersigned shall be binding upon the successors and
assigns of the Undersigned from the date of this Lock-Up Agreement.

 

    	 

    	 

    

 

This Lock-Up Agreement
shall automatically terminate and be of no further effect upon the earliest to occur, if any, of the following: (i) prior to the
execution of the Underwriting Agreement, upon such date the Company, on the one hand, or you, on the other hand, notifies the other
in writing that it does not intend to proceed with the Public Offering, (ii) the date that the Company withdraws the registration
statement related to the Public Offering, or (iii) upon the termination (other than the provisions thereof that survive termination)
of the Underwriting Agreement in accordance with the terms thereof prior to payment for and delivery of the Shares to be sold thereunder.

 

This Lock-Up Agreement
shall be governed by and construed in accordance with the laws of the State of New York, without regard to the conflict of laws
principles thereof. Delivery of a signed copy of this Lock-Up Agreement by facsimile or e-mail/.pdf transmission shall be effective
as the delivery of the original hereof.

 

In Witness Whereof, the Undersigned
hereby agrees to the above on the date set forth above.

 

	 	By:______________________________________________
	 	 
	 	Name:___________________________________________________
	 	 
	 	Title:___________________________________________________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}]]